Rhabdomyoma historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
{{Rhabdomyoma}}
{{Rhabdomyoma}}
{{CMG}}{{AE}}{{Simrat}}
{{CMG}}{{AE}}{{Simrat}}
==Overview==
Enteropathy-associated T-cell Lymphoma (EATL), also enteropathy-type T-cell lymphoma (ETTL), is a type of T-cell [[Non-Hodgkin lymphoma|non-hodgkin lymphoma]] that affects the [[small intestine]], it is composed of large [[lymphoid]] cells. Enteropathy-associated T-cell lymphoma has two subtypes, type I enteropathy-associated T-cell lymphoma which has a strong association with [[celiac disease]] and it is more common in western countries and type II enteropathy-associated T-cell lymphoma which is mostly found among the Asian population. [[Genes]] involved in the [[pathogenesis]] of this disease include 8q24, [[T-cell receptor]] (TCR) beta and gamma, and 16q genes. On gross [[pathology]], multiple [[intestinal]] ulcers are characteristic findings of EATL. On microscopic [[histopathological]] analysis, monotonous cells, round or angulated vesicular [[nuclei]], and prominent [[nucleoli]] are characteristic findings of enteropathy-associated T-cell lymphoma. There are no established causes for enteropathy-associated T-cell lymphoma. EATL must be differentiated from other diseases such as [[peptic ulcer]], poorly-differentiated [[adenocarcinoma]], [[MALT lymphoma]], [[diffuse large B cell lymphoma]], and [[mantle cell lymphoma]].
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 16:32, 10 January 2019

Rhabdomyoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rhabdomyoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rhabdomyoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rhabdomyoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rhabdomyoma historical perspective

CDC on Rhabdomyoma historical perspective

Rhabdomyoma historical perspective in the news

Blogs on Rhabdomyoma historical perspective

Directions to Hospitals Treating Rhabdomyoma

Risk calculators and risk factors for Rhabdomyoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Enteropathy-associated T-cell Lymphoma (EATL), also enteropathy-type T-cell lymphoma (ETTL), is a type of T-cell non-hodgkin lymphoma that affects the small intestine, it is composed of large lymphoid cells. Enteropathy-associated T-cell lymphoma has two subtypes, type I enteropathy-associated T-cell lymphoma which has a strong association with celiac disease and it is more common in western countries and type II enteropathy-associated T-cell lymphoma which is mostly found among the Asian population. Genes involved in the pathogenesis of this disease include 8q24, T-cell receptor (TCR) beta and gamma, and 16q genes. On gross pathology, multiple intestinal ulcers are characteristic findings of EATL. On microscopic histopathological analysis, monotonous cells, round or angulated vesicular nuclei, and prominent nucleoli are characteristic findings of enteropathy-associated T-cell lymphoma. There are no established causes for enteropathy-associated T-cell lymphoma. EATL must be differentiated from other diseases such as peptic ulcer, poorly-differentiated adenocarcinoma, MALT lymphoma, diffuse large B cell lymphoma, and mantle cell lymphoma.

References

Template:WH Template:WS